Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Clinical trial NCT04068597 · RECRUITING

Trial details

NCT number: NCT04068597
Sponsor: CellCentric Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Haematological Malignancy Acute Myeloid Leukemia Non Hodgkin Lymphoma Multiple Myeloma Higher-risk Myelodysplastic Syndrome Peripheral T Cell Lymphoma

Start date: 2019-08-09
Primary completion: 2027-03-31
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.